The Medicinal Cannabis Council Australia (MCCA) has announced the appointment of Geoff Bloom as its new chair. This leadership transition comes as discussions continue regarding the composition of the council’s inaugural board, particularly concerning the representation of cultivation expertise within the Australian medicinal cannabis sector.
New Leadership at Medicinal Cannabis Council Australia
Geoff Bloom, a lawyer affiliated with Mills Oakley, was selected to lead the Medicinal Cannabis Council Australia by his six fellow board directors. These directors were elected earlier this month from a pool of 18 nominees, as reported by Cannabiz AU. Bloom’s background in legal practice aligns with the council’s mandate to navigate the complex regulatory and policy landscape surrounding medicinal cannabis in Australia.
The appointment of the new chair follows the formation of the MCCA’s inaugural board, which was previously covered by Hemp Gazette. The council aims to represent the interests of the medicinal cannabis industry, engaging with stakeholders across the supply chain, from cultivation and manufacturing to prescribing and patient access.
Board Composition and Industry Representation
Concerns have been raised within the industry regarding the initial composition of the Medicinal Cannabis Council Australia board, specifically the absence of direct representation from cannabis cultivators. Bloom acknowledged these concerns, stating that he sees merit in incorporating cultivation expertise onto the board. This perspective suggests a potential future adjustment to the council’s structure to ensure a broader range of industry voices are included in its governance.
Industry bodies like the MCCA play a role in advocating for policy changes, facilitating industry standards, and fostering collaboration among members. Diverse representation, including growers, manufacturers, distributors, and medical professionals, is often considered crucial for these organisations to effectively address the varied challenges and opportunities within a developing sector such as medicinal cannabis.
The Role of Cultivation Expertise
The cultivation segment is fundamental to the medicinal cannabis supply chain, involving specialised knowledge in horticulture, genetics, quality control, and compliance with Good Agricultural and Collection Practices (GACP). The absence of a dedicated grower representative on the MCCA board has prompted calls for a more inclusive approach to ensure that the unique perspectives and operational realities of cultivators are directly considered in the council’s strategic direction and advocacy efforts.
As the Australian medicinal cannabis market continues to mature, the structure and representation within key industry associations like the Medicinal Cannabis Council Australia will likely remain a subject of ongoing discussion among stakeholders seeking to shape the sector’s future.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hemp Gazette does not provide medical recommendations, diagnoses, or treatment plans. Always consult a qualified healthcare practitioner before making any decisions regarding your health or any medical condition. Statements concerning the therapeutic uses of hemp, cannabis, or cannabinoid-derived products have not been evaluated by Australia’s Therapeutic Goods Administration (TGA). Medicinal cannabis products in Australia are accessed via prescription pathways under TGA regulation.
